Literature DB >> 15041895

A rational use of laboratory tests in the diagnosis and management of hepatitis C virus infection.

Gianna Dal Molin1, Claudio Tiribelli, Cesare Campello.   

Abstract

The prevalence of HCV infection is very diversified according to geographical areas and ranges from 1% in the Northern regions of the world to more than 20% as we move South. Due to the presence of HCV-associated liver diseases and the development of effective treatments, the diagnosis of HCV infection is a growing medical need. Several tests are available, from simple screening to identify the presence of anti-HCV antibodies to the more sophisticated quantification of viral load and genotyping. However, these tests are to be used in a logical, consequential and cost-effective manner. This review article will report on the protocol in use in the North-Eastern part of Italy for the screening and diagnosis of HCV infection. The protocol is based on a consensus among several experts and may be the basis for a more rational approach in this rapidly growing field.

Entities:  

Mesh:

Year:  2003        PMID: 15041895

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  5 in total

Review 1.  The epidemiology of hepatitis C infection in the United States.

Authors:  Vinod K Rustgi
Journal:  J Gastroenterol       Date:  2007-07-25       Impact factor: 7.527

2.  Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico.

Authors:  Nahum Méndez-Sánchez; Daniel Motola-Kuba; Norberto C Chavez-Tapia; Jesús Bahena; Ricardo Correa-Rotter; Misael Uribe
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

3.  Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA.

Authors:  N Choudhury; Sunita Tulsiani; Priti Desai; Ripal Shah; Ankit Mathur; V Harimoorthy
Journal:  Asian J Transfus Sci       Date:  2011-01

4.  Significance of anti-HCV signal-to-cutoff ratio in predicting hepatitis C viremia.

Authors:  Yeon Seok Seo; Eun Suk Jung; Jeong Han Kim; Young Kul Jung; Ji Hoon Kim; Hyonggin An; Hyung Joon Yim; Jong Eun Yeon; Kwan Soo Byun; Chang Duck Kim; Ho Sang Ryu; Soon Ho Um
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 3.165

5.  True positivity of anti-Hepatitis C Virus Enzyme-linked immunosorbent assay reactive blood donors: A prospective study done in western India.

Authors:  Sunita Tulsiani; Nabajyoti Choudhury; Priti Desai; Ripal Shah; Ankit Mathur; V Harimoorthy; Jwalant Shah
Journal:  Asian J Transfus Sci       Date:  2012-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.